IPO was $0.20. Hit a high of $0.56 or so shortly after. Much of the initial years were spent focusing on capital investments and building partnerships. A string of ups and downs since then. And now we sit at $0.02.
Hopefully, TGA approval for the pregnancy test, growth of the HIV business, FebriDX growth in the US, and FDA approval of the pregnancy test, will change things. Of course, all of this will take quite some time - read: years. A bit of good luck wouldn't hurt either!
AT1 Price at posting:
2.5¢ Sentiment: Hold Disclosure: Held
